 |
市場調查報告書
商品編碼
1550643
乾癬性關節炎治療的全球市場：按藥物類別、按產品類型、按給藥途徑、按分銷管道、按地區Psoriatic Arthritis Treatment Market, By Drug Class, By Product Type (Prescription and Over The Counter ), By Route of Administration, By Distribution Channel, By Geography |
||||||
全球乾癬性關節炎治療市場規模預計將從 2024 年的 111 億美元增加到 2031 年的 211.1 億美元，2024-2031 年複合年成長率為 9.6%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 111億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測 2024-2031 年複合年成長率： | 9.60% | 2031年價值預測 | 211.1億美元 |
乾癬性關節炎是一種與乾癬同時發生的慢性發炎關節炎。據估計，大約 30% 的乾癬患者會患上乾癬性關節炎。這種疾病會導致關節內和周圍疼痛、僵硬和腫脹。隨著時間的推移，乾癬性關節炎會對您的關節造成永久性損傷。常規治療用於控制症狀，包括胺基甲基葉酸和 TNF 抑制劑等緩解疾病抗風濕藥物 (DMARD)。全球乾癬性關節炎治療市場的成長是由安全性和療效更好的新型生物目標的不斷開發和核准所推動的。
市場動態：
全球乾癬性關節炎治療市場的成長是由全球乾癬性關節炎盛行率不斷上升所推動的。據估計，該病的全球盛行率在0.06%至1%之間。此外，人們對該疾病的認知不斷提高以及先進治療方法的可用性也正在推動市場成長。然而，生物製藥的高成本可能會阻礙市場成長，特別是在價格敏感的新興市場。市場公司不斷努力開發具有成本效益的生物製藥學名藥藥，可以隨著時間的推移降低成本。此外，新興國家不斷成長的醫療保健支出可能會在不久的將來為市場公司提供新的機會。
本研究的主要特點
本報告對全球乾癬性關節炎治療市場進行了詳細分析，包括以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、業績和策略等參數對全球乾癬性關節炎治療市場的主要企業進行了分析。
研究涵蓋的主要企業包括輝瑞、強生、艾伯維、諾華、UCB、禮來和百時美施貴寶。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球乾癬性關節炎治療市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球乾癬性關節炎治療市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章 市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特的分析
- 併購場景
第4章全球乾癬性關節炎治療市場：依藥物類別（2019-2031）
- 生技藥品
- 非生技藥品
- 聯合治療
第5章全球乾癬性關節炎治療市場：依產品類型（2019-2031）
- 處方箋
- 店面銷售(OTC)
第6章全球乾癬性關節炎治療市場：依給藥途徑（2019-2031）
- 胃腸外的
- 口服
第7章全球乾癬性關節炎治療市場：依通路分類（2019-2031）
- 院內藥房
- 零售藥房
- 網路藥房
第8章全球乾癬性關節炎治療市場：按地區（2019-2031）
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
第9章 競爭格局
- Medtronic
- Johnson & Johnson（DePuy Synthes）
- Zimmer Biomet
- Stryker
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics
第10章分析師建議
- Wheel of Fortune
- 分析師觀點
- Coherent Opportunity Map（COM）
第11章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Global psoriatic arthritis treatment market is estimated to be valued at USD 11.10 Bn in 2024 and is expected to reach USD 21.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 11.10 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.60% | 2031 Value Projection: | US$ 21.11 Bn |
Psoriatic arthritis is a chronic inflammatory arthritis that occurs in conjunction with psoriasis. It is estimated that around 30% of people with psoriasis may develop psoriatic arthritis. The disease causes pain, stiffness and swelling in and around the joints. Over time, psoriatic arthritis can cause permanent damage to the joints. Conventional treatments including disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and TNF inhibitors are used to manage the symptoms. Global psoriatic arthritis treatment market growth is driven by rising development and approval of novel targeted biologic therapies with better safety and efficacy profiles.
Market Dynamics:
Global psoriatic arthritis treatment market growth is driven by growing prevalence of psoriatic arthritis worldwide. According to estimates, the global prevalence of the disease ranges between 0.06% to 1%. Moreover, increasing awareness about the disease and availability of advanced treatments can also drive the market growth. However, high cost of biologic therapies can hamper the market growth, especially in price-sensitive developing regions. Continued efforts by market players to develop cost-effective generic versions of biologics can reduce costs over time. Furthermore, rising healthcare expenditures in emerging nations can offer new opportunities for the market players in the near future.
Key features of the study:
This report provides in-depth analysis of the global psoriatic arthritis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global psoriatic arthritis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Eli Lilly, Bristol-Myers Squibb
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global psoriatic arthritis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global psoriatic arthritis treatment market
Detailed Segmentation-
- Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
- Biologics
- Non-biologics
- Combination Therapy
- Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Prescription
- Over-The-Counter (OTC)
- Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Parenteral
- Oral
- Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Johnson & Johnson (DePuy Synthes)
- Zimmer Biomet
- Stryker
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Psoriatic Arthritis Treatment Market, By Drug Class
- Global Psoriatic Arthritis Treatment Market, By Product Type
- Global Psoriatic Arthritis Treatment Market, By Route of Administration
- Global Psoriatic Arthritis Treatment Market, By Distribution Channel
- Global Psoriatic Arthritis Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Non-biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Combination Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Psoriatic Arthritis Treatment Market, By Product Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Over-The-Counter (OTC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Psoriatic Arthritis Treatment Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020- 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson (DePuy Synthes)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
